We now report the identification and preliminary functional characterization of four distinct murine MPO promoters.
Introduction
The enzyme myeloperoxidase (MPO; donor: H 2 O 2 oxidoMaterials and methods reductase EC1.11.1.7) is an important constituent of the oxygen-dependent bacterial killing system of granulocytes and Propagation of cells monocytes. 1 Since it is expressed only in cells of the myeloid lineage, MPO has been widely used to classify and diagnose acute leukemias. 2 A constituent of the primary granules of The murine myeloblastic cell line 32D c13 was graciously neutrophils and monocytes, MPO is synthesized only during provided by Dr Joel S Greenberger (University of Pittsburgh) the late myeloblastic and promyelocytic stages of myeloid and was propagated in Iscove's modified Dulbecco's medium maturation.
3,4 MPO enzyme activity has been seen in mature supplemented with 10% heat-inactivated fetal bovine serum myeloid cells of all mammalian species examined, but the and 5% WEHI-3B conditioned medium, as a source of IL-3. expression of this gene has been studied most extensively in Granulocytic differentiation of these cells was induced by murine and human cells. Both human and murine MPO treatment with 5 ng/ml of recombinant murine granulocyte appear to be encoded by a single gene 5, 6 and the respective colony-stimulating factor (G-CSF) (R&D Systems, Minneapolis, genes have been cloned and sequenced. 7, 8 Regulation of MN, USA). The murine monocytic cell line WEHI 3 and the MPO gene expression appears to occur primarily at the tranmurine fibroblast cell line 3T3 were obtained from the Ameriscriptional level.
9-11 Human myeloid cells appear to contain can Type Culture Collection (Rockville, MD, USA). These cell several size classes of MPO RNA, but all cDNAs which have lines were maintained in Iscove's modified Dulbecco's been examined to date appear to share the same initiation medium. The human cell lines HL-60 (myeloblastic), K-562 site, [12] [13] [14] suggesting the presence of only one functionally (erythroleukemic), and HeLa (squamous carcinoma) were important human MPO promoter. On the other hand, analysis obtained from the American Type Culture Collection. Except of murine MPO RNA has revealed several distinct 5Ј-termini, where otherwise noted, the cell lines were grown in humidisuggesting the possible existence of multiple murine MPO fied 5% CO 2 at 37°C in RPMI 1640 (Gibco BRL, Gaithersburg, promoters. 15, 16 MD, USA) supplemented with 1% l-glutamine, 100 U/ml We recently reported the identification and characterization penicillin, 100 g/ml streptomycin, and 10% heat-inactivated of the human MPO promoter, 17 and have subsequently fetal calf serum. Cells were harvested by centrifugation and described the mapping and functional analysis of a series of washed in phosphate-buffered saline (pH 7.4) before processing. Protein concentration in cell extracts was determined by measuring absorbance at 280 and 260 nm. Genomic DNA Correspondence: GE Austin, Laboratory Service (113), Atlanta VA was extracted from urine or human cells as described by Sambrook et al. 26 Analysis of 5Ј-flanking DNA sequences of murine and
Results

human DNA
Our recent studies of the human MPO promoter [17] [18] [19] [20] demonstrated the existence of seven discrete, functionally important The published sequences of the 5Ј-flanking region of the nuclear protein binding sequences (which we termed DP1-human and murine MPO genes were obtained from Gene-DP7) in the proximal 5Ј-flanking region of the human MPO Bank R86.0, December 1994 version, compiled by the US gene. Mutation of sites DP1, DP2, DP3, DP4 or DP5 reduced National Institutes of Health and distributed by Hitachi promoter activity, while mutation of sites DP6 or DP7 resulted Software Engineering (San Bruno, CA, USA). Regions of homoin increased reporter expression. Because the endogenous logy between the murine and human MPO genes were commurine MPO promoter had not been localized and characpared using the software program MacDNASIS Pro version 3.4 terized previously, we compared the DNA sequences of the Sequence Analysis Software (Hitachi Software Engineering).
murine and human MPO genes to look for sequences in the murine MPO gene which were homologous to the nuclear protein binding sequences in or adjacent to the minimal promoter of the human MPO gene. As shown in Figure 1 , a 218-Construction of luciferase reporter plasmids containing bp segment from the 3Ј-end of exon 0 of the murine MPO portions of the murine or human MPO genes gene (terminology of Friedman et al 16 ) contains sequences which are highly homologous to sites DP1 to DP4 of the human MPO promoter region. Sites DP1-DP4 of the human Selected segments of the 5Ј-flanking or adjacent coding MPO gene lie in the 5Ј-flanking region between bp −157 and regions of the murine or human MPO genes were amplified bp +10, and include the three major nuclear protein binding by PCR using GeneAmp kits (Perkin-Elmer Cetus, Norwalk, sites which comprise the minimal promoter, as well as an CT, USA) as previously described. 17, 18 To prepare luciferase adjacent sequence that enhances promoter activity. The four reporter plasmids containing portions of murine or human corresponding sites in the murine MPO gene lie between MPO promoter DNA, the amplified promoter segments were bp 1547 and bp 1690 (numbering from the 5Ј end of the gene; inserted into BglII and HindIII sites of pGL-2 Basic vector or see GeneBank accession number X 15378) in the same relapGL-3-Basic vector (Promega, Madison, WI, USA). Luciferase tive orientation as in the human gene. The DP1 homologue reporter plasmids containing different length segments of in the murine gene is situated at the 3Ј-end of exon 0, directly MPO promoter DNA were prepared by amplifying these variupstream from a major initiation site for murine MPO tranous MPO DNA segments using primers containing BglII and scription in G-CSF-treated 32D cl3 cells. [16] [17] [18] [19] [20] [21] [22] HindIII handles, and inserting the products into the BglII and To determine if this fragment of murine MPO DNA had proHindIII sites of plasmid pGL-2-Basic or pGL-3-Basic moter activity, we amplified a DNA segment consisting of (Promega). Plasmid pSV-␤-galactosidase Control, which was bp 1513 to bp 1713 of the murine MPO gene, which includes used as an internal control for transfection studies, was the sequences homologous to sites DP1 to DP4 of the human obtained from Promega and was grown in Escherichia coli MPO gene. We inserted this segment into plasmid pGL-2 HB101. ␤-galactosidase activity was measured by conversion Basic directly upstream from a luciferase reporter, and assayed of substrate ONPG (o-nitrophenyl-␤-d-galactopyranoside) to it for promoter activity in transfected cells. As shown in Figure  a yellow product which was determined by measuring 2, this DNA segment exhibited substantial promoter activity, absorbance at 420 nm. 27 comparable to that which we previously reported for the minimal human MPO promoter (Refs 17 and 18; see also Figure  5 below). We named this murine promoter 'P1'. As shown in Table 1 below, this promoter showed no specificity for MPOTransient transfection by electroporation or using expressing cells, consistent with it being a minimal promoter.
Lipofectamine reagent
A plasmid containing the murine DNA segment from bp 1513 to bp 1649 (lacking the murine homologue of DP1 and part of the DP2 homologue) showed essentially no promoter activity Leukemic cell lines were transfected by electroporation as previously described, 17 using a Gene Pulser System (BioRad, compared with the promoterless negative control plasmid (Figure 2) . Hence, the segment of the murine MPO gene Richmond, CA, USA) or a PZ200 Progenator II (Hoeffer, San Francisco, CA, USA). Electroporetic transfections were carried between bp 1650 and bp 1713 is required for minimal promoter activity, as predicted from its homology with the human out in a volume of 400 l OPTI-MEM I (Gibco BRL Life Technologies, Gaithersburg, MD, USA) without serum at 250 V, MPO promoter. In the human promoter a CATAA sequence located from bp Ϫ26 to bp −22 (along with adjacent 3Ј 960 F, and Tau of 39 ms using 30-40 g of plasmid DNA and 0.8 to 1.0 × 10 7 cells. HeLa cells were transfected using sequences up to bp +10) is essential for nuclear protein binding to site DP1 and for promoter activity. The homologous Lipofectamine reagent (Gibco BRL) using 5 g plasmid DNA and 10 6 cells. To normalize for efficiency of transfection, cells CATAA sequence in the murine P1 promoter is located from bp 1668 to bp 1672, about 25 bases upstream from the putawere cotransfected with plasmid pSV-␤-galactosidase control vector (Promega) (0.5 g for HeLa cells, 1.0 g for the electrotive initiation site for transcription. A plasmid containing a longer segment of 5Ј-flanking murine MPO DNA (bp 1213 to poretic procedure). 28 For luciferase reporter plasmids aliquots of 3 × 10 6 cells were lysed in 200 l lysis buffer (Promega) for bp 1713) showed similar promoter activity to that of the 200 bp P1 promoter, suggesting that the entire P1 minimal 15 min at room temperature. Luciferase activity was assayed with a luciferase assay kit from Promega using 20 l of cell promoter was contained between bp 1513 and bp 1713. However, a still longer segment (bp 978 to 1713) contained extract and an ML3000 Microtiter Plate Luminometer (Dynatech Laboratories, Chantilly, VA, USA). Results were increased activity, suggesting the presence of either enhancer elements or additional promoters upstream from promoter P1. expressed as relative light units (RLU) luciferase activity per OD 420 ␤-galactosidase.
A plasmid containing the DNA segment from bp 978 to 1649
Figure 1
Sequence homologies between the principal human MPO promoter and the 3Ј-end of exon 0 of the murine MPO gene. DP1, DP2, DP3 and DP4 are functionally important nuclear protein binding sites in the human MPO promoter region. Base numbers for the murine MPO gene are from GeneBank R860, December 1994, compiled by the US National Institutes of Health. The base numbering system for the human MPO gene is that of Johnson et al. 7 Hyphens indicate bases missing from either the human or murine DNA sequence.
Figure 2
Demonstration of promoter activity in segments of exon 0 of the murine MPO gene which contain sequences homologous to the human MPO promoter. Plasmid constructs containing the indicated portions of the murine MPO gene in luciferase reporter plasmid pGL-2 were assayed in transiently transfected cells. The murine MPO promoter (P1) homologous to the principal human MPO promoter is located between bp 1650 and bp 1713 of the murine MPO gene. Arrows indicate the apparent transcription sites for MPO RNA species, as reported by Friedman et al. 16 Luciferase activities represent mean ± s.e.m. for five to seven experiments. The negative control plasmid (pGL-2-Basic) lacks a promoter; the positive control plasmid (pGL2-Promoter) contains an SV40 early promoter. (thus lacking the minimal P1 promoter) had significant prostantially lower activity. Hence, the segment from bp 1400 to bp 1541, which includes the CATAA site at bp 1417 to moter activity, providing further support for the existence of additional upstream promoters.
bp 1421, is the apparent location of a weak promoter, which we term 'P2'. The promoter activity in this segment does not As mentioned above, murine MPO mRNA has been shown to be comprised of several size classes. 15 , 16 Venturelli et al 15 appear to be simply residual P1 activity (due to the 28 bp overlap with P1), since the segment from bp 1513 to bp 1649 studied the sequence of several murine MPO cDNA clones and showed them to have differing 5Ј-termini, suggesting the shows no promoter activity. A plasmid containing the murine MPO DNA segment from existence of multiple transcription initiation sites. Friedman et al 16 analyzed murine MPO RNA in 32D cl3 cells which had bp 978 to bp 1224 (including the CATAA site at bp 1036 to bp 1040) showed high luciferase activity, suggesting that it been treated with the growth factor G-CSF. By Northern blotting and primer extension experiments these authors provided contains the promoter responsible for the longest murine MPO transcripts (which initiate at bp 1207, Ref. 15). We named the evidence for four distinct initiation sites for murine MPO transcription. The two major initiation sites for these transcripts putative promoter contained within this segment 'P3'. A plasmid containing additional murine sequences downstream were at the 3Ј-end of exon 0 (corresponding with promoter P1, which we have just described) and in intron 1, adjacent from bp 1224 (bp 978 to bp 1400) showed lower promoter activity than P3, suggesting that the region between bp 1224 to the 5Ј-end of exon 1. The initiation sites for the remaining 10-20% of the murine MPO transcripts were thought to be and bp 1400 did not contain a promoter. Likewise, a plasmid containing additional DNA sequences at the 5Ј-end of P3 further upstream, at the 5Ј end of exon 0 and in the middle of that exon.
(bp 793 to bp 1224) showed only about one half as much activity as P3, suggesting that it contained additional inhibiWe examined each of these additional segments of the murine MPO gene for sequences which might resemble those tory sites but no additional promoters. Plasmids containing various portions of the DNA segment between bp 793 and of known promoters. CATAA sites were found at bp 1036 to bp 1040 (about 170 bp upstream from the 5Ј end of exon 0), bp 1103 exhibited no promoter activity. Hence, the 122 bp segment between bp 1103 and bp 1224 is required for, and and in the middle of exon 0 (bp 1417 to bp 1421), suggesting that these might be the sites of the promoters rsponsible for apparently contains the minimal P3 promoter. This segment includes the proximal enhancer (AACCACA, bp 1102-1108) the longer transcripts observed in vivo. In addition, a TATAA site was found at bp 1810 to 1814, near the middle of intron previously described by Friedman 16 and colleagues, 21, 22 which may account for the relatively high activity of promoter 0. This site is about 300 bp upstream from the putative initiation site for the shortest MPO RNA transcripts. To deter-P3 in transfected cells, compared with the reportedly small fraction of MPO RNA initiated at this site. This segment does mine if DNA segments containing these CATAA or TATAA sites had promoter activity, we prepared a series of plasmid not include a TATAA sequence but does contain a GATAA sequence at bp 1158-1162 which may perhaps be involved constructs (in the luciferase reporter plasmid, pGL-2) containing portions of exon 0, segments of DNA directly upstream in promoter function. A CATAA sequence and an initiator-like sequence lie further upstream at bp 1036-1048 but, based from exon 0, or portions of the first intron of the murine MPO gene. Figure 3 shows the promoter activity of each of these upon their location, these seem unlikely to be constituents of the minimal P3 promoter. constructs in transiently transfected murine or human cells.
As indicated above, a plasmid containing a 564 bp DNA The remaining putative initiation site for MPO transcription, which has been described in murine leukemic cell lines is at segment directly upstream from promoter P1 (bp 978 to bp 1649) showed substantial promoter activity, suggesting that the 3Ј-end of the first intron, near bp 2100. To look for the promoter responsible for these transcripts, a plasmid containit contained one or more additional promoters. Likewise, a plasmid containing a 328 bp segment from bp 1213 to ing a 431 bp murine MPO DNA segment from bp 1695 to bp 2125 was constructed and examined in transfection experibp 1541, lacking the extreme 5Ј-end of exon 0, but including the remainder of the 5Ј-end and the middle of exon 0, showed ments. This segment showed significant, though low promoter activity. A plasmid containing a slightly shorter (398 bp) segsome luciferase reporter activity above background, suggesting the presence of a weak promoter within this segment. A ment (from bp 1728 to bp 2125) showed greater activity and was named 'promoter P4'. This segment contained a TATAA plasmid containing the segment from bp 1213 to bp 1400 (but lacking the segment from bp 1400 to bp 1541) showed subsequence at bp 1811 to bp 1815. However, a plasmid con-
Figure 3
Localization of promoters P2, P3 and P4 in the 5Ј-flanking and adjacent coding region of the murine MPO gene. Plasmid constructs containing the indicated portions of the murine MPO gene in luciferase reporter plasmid pGL-2 were assayed for luciferase activity in transiently transfected cells. Arrows indicate the apparent transcription sites for MPO RNA species, as reported by Friedman et al. 16 Luciferase activities represent mean ± s.e.m. for five to seven experiments. The negative control plasmid (pGL2-Basic) lacks a promoter; the positive control plasmid (pGL2-Promoter) contains an SV40 early promoter. taining only the upstream half of P4 (bp 1728 to bp 1894), promoter P3 was the most active of the four murine MPO promoters in all three cell lines tested, P4 the next most active, including the TATAA sequence, showed much lower activity than did the entire P4 sequence. Likewise, a plasmid containand P1 the third most active, while P2 showed the lowest activity. Following treatment of the cells for 24 h with G-CSF, ing the 3Ј-end of P4 (bp 1841 to bp 2125) but lacking the TATAA sequence showed little activity. Hence, P4 appears promoter P3 showed about a 40% increase in activity (20-70% in individual experiments), while the activity of the other to require both upstream sequences, probably including the TATAA sequence, and also downstream sequences (between three murine MPO promoters as well as that of the SV40 promoter in the positive control plasmid remained essentially bp 1895 and bp 2125) for full activity. A pyrimidine-rich sequence closely resembling a consensus initiator sequence 28 unaffected by G-CSF. Table 2 illustrates the results of another series of experiments, in which luciferase activity in uninis located between bp 2080 and bp 2100, and could possibly be important for promoter function. However, further studies duced and G-CSF-treated 32D cl3 cells was compared at 18, 24 and 48 h after transfection. Again, promoter P3 showed will be required to clarify this issue.
Plasmid constructs created using pGL-2 vectors (Promega) slightly greater activity in G-CSF-treated cells at all timepoints, compared with untreated cells, whereas the activities generally show low levels of reported activity when transfected into MPO-expressing leukemic cell lines, possibly of promoters P1, P2 and P4 were essentially unaffected by G-CSF treatment. because of the high levels of degradative enzymes present in the primary granules of these cells. Hence, to study the Extensive work by Morishita et al, 11 Hashinaka et al 14 and Chang et al 12 has demonstrated that most, if not all, MPO tranactivity of the four murine MPO promoters in leukemic cells we used the recently available pGL-3 vector (Promega), which scription in human myeloid cells employs a single initiation site, whose location corresponds with that of our previously has been modified to improve luciferase expression. Table 1 compares the relative activities of murine MPO promoters P1, described MPO promoter (human P1). However, a homology plot comparing the sequences of human and murine MPO P2, P3 and P4 in three murine leukemic cell lines: NIH 3T3 (which does not express MPO in vivo), WEHI-3 (which DNA (Figure 4) shows extensive sequence similarity between the segments of murine MPO DNA containing promoters P2 expresses MPO at a very low level in vivo), and 32D c13 (which expresses low-to-moderate levels of MPO in the uninand P3 (bp 1000 to bp 1550) and the region of the human MPO gene lying between bp −1100 and bp −500. (The murine duced state and high levels of MPO following treatment of the cells with granulocyte colony-stimulating factor (G-CSF). 16 All P4 region shows no homology with the human MPO gene.) Furthermore, Rovera reported evidence for minor usage of four murine MPO promoters showed greatest activity in NIH-3T3 cells, lowest activity in WEHI-3 cells, and intermediate more upstream human MPO initiation sites (cited by Friedman et al 16 and Nausfeef
29
). Hence, we prepared luciferase levels of activity in uninduced 32D cl3 cells. Using this vector Table 2 Activity of murine MPO promoters in 32D cl3 cells at various times after treatment with G-CSF reporter plasmid constructs containing segments of 5Ј-flanking Likewise, based upon sequence homology, the human equivalent of murine P3 should lie between bp −1200 and human MPO DNA which showed sequence homology to murine MPO promoters P2 and P3, and analyzed these plasbp −1000, although no CATAA or TATAA sequence is present within this region. In fact, a plasmid containing the human mids for promoter activity in transient transfection studies. These results are shown in Figure 5 .
Plasmid
DNA segment between bp −1271 and bp −1013 shows appreciable promoter activity ( Figure 5 ), though much less Based upon sequence comparisons, the human homologue of murine MPO promoter P2 should lie between bp −700 and than that seen with the corresponding murine P3 promoter. Since the plasmid containing the murine DNA segment from bp −500 of the human MPO gene. Although no TATAA or CATAA sequence is located in this part of the human gene, a bp −1088 to bp −924 has no promoter activity, the human P3 equivalent appears to lie in the 182 bp segment between plasmid containing the human MPO DNA segment from bp −1088 to bp −523 does, in fact, show low but detectable bp −1271 and bp −1089. promoter activity in transient transfection experiments ( Figure  5 ). On the other hand, a plasmid containing the DNA segments from bp −1088 to bp −924 shows almost no activity. Discussion Hence, a weak homologue of murine promoter P2 appears to lie in the expected position in the human MPO gene, between
Our transfection results clearly demonstrate promoter activity in each of four distinct segments of the murine MPO gene. bp −924 and bp −523. The locations of these four promoters correspond closely to While our work suggests that all four promoters are capable of initiating transcription of the MPO gene, none of the minithe four MPO transcriptional initiation sites previously demonstrated by analysis of MPO RNA populations and sequencing mal promoters, in itself, shows specificity for cells which express MPO in vivo. Additional regulatory elements must be of cDNA clones. 15, 16 However, several discrepancies are evidence between the relative activities of the four promoters required to produce the high level of tissue-specific and maturation stage-specific transcription of the MPO gene observed which we observed in transfection experiments, and the relative frequencies with which each of the corresponding in vivo. We have recently described a series of cis-elements in the promoter region of the human MPO gene which are initiation sites are reported to be used for MPO transcription in vivo. Evidence referred to above indicates that most MPO capable of modulating the activity of the minimal human MPO P1 promoter, and similar elements undoubtedly exist in RNA species have 5Ј-termini which correspond in location to promoters P1 and P4. In contrast, our current transfection the murine MPO gene. 17, 18 It will be necessary to characterize the interactions of these various cis-elements and their assostudies show P3 promoter to have the highest activity, both in MPO-expressing cells such as 32D cl3 and WEHI-3, and ciated transacting protein factors, with each of the four murine MPO promoters, in order to understand the way in which in MPO-non-expressing cells such as NIH-3T3 or HeLa. The reasons for the relatively strong activity of P3 relative to the MPO expression is regulated in normal and neoplastic myeloid cells. activity of the other promoters are not yet clear. It is possible that the presence within the P3 promoter segment of the proxiIt is not entirely clear why significant levels of endogenous murine MPO promoter activity have not been detected premal enhancer previously described by Suzoh and Friedman 21 is responsible for the relative strength of the P3 activity in viously by other investigators who have studied this problem. It is true that promoter P1 is located downstream from the site transfected cells. Perhaps in vivo this enhancer may stimulate the activity of all four promoters. examined in detail by Suzoh and Friedman 21 but promoter P3 lies within the segment of the proximal 5Ј-flanking region Promoters P1 and P4 also show substantial activity in transfected cells. Using the pGL3 vector, promoter P4 showed which those workers studied. One reason undoubtedly is the difficulty in obtaining high levels of luciferase reporter activity greater activity than P1 in all murine cell lines tested. However, for reasons not yet clear, using the pGL2 vector, P1
in transfected leukemic cells with most currently available plasmids. This difficulty appears due, at least in part, to the activity is greater than P4 activity in both HeLa and NIH 3T3 cells. Finally, promotor P2 shows the lowest activity of the numerous proteases present in the primary granules of myeloid precursors. It appears that the luciferase reporter plasfour promoters in all cell lines tested, in agreement with previous evidence that the corresponding initiation site is responmid pGL-2 (Promega) which we and others have previously employed in transfection studies involving leukemic cells, is sible for only a small minority of the MPO transcripts synthesized in vivo.
targeted to the lysosomal granules present in many of these cell lines. This problem seems not to apply to cell lines of shows heterogeneity at its 5Ј-end suggests that this form of regulation may occur in the MPO gene as well. Indeed, our other lineages which have fewer lysosomal granules. Our studies demonstrate that the recently available pGL-3 vectors initial studies of changes in MPO promoter activity in 32D cl3 cells following treatment with G-CSF suggest that the increase (Promega) partially overcome this problem. We were able to obtain substantially higher luciferase reporter activity in 32D in MPO transcription following induction of maturation with this agent may be due primarily to a stimulation of the activity cl3 cells using pGL-3 plasmids than we obtained using plasmids derived from the pGL-2 vectors. The availability of these of promoter P3. Furthermore, Chang et al 12 showed changes in the expression level of different size classes of human MPO newer vectors should facilitate studies of transcription in leukemic cell lines.
RNA after induction of HL-60 cells with TPA. Although those authors attributed the changes they observed to differential Of the four murine MPO promoters we have detected, only promoter P4 contains a true TATA element (bp 1811-1816).
splicing it is possible that the use of multiple promoters may be involved as well. Further studies will be needed to clarify However, activity of this promoter appears to be dependent also upon sequences substantially downstream from the TATA the relative roles of these and other mechanisms in the modulation of MPO expression in developing myeloid cells and in element. A pyrimidine-rich sequence closely resembling a consensus initiator sequence is present near bp 2090, but myeloid neoplasms. further studies will be required to determine if this sequence has functional importance.
On the other hand, murine P1, P2 and P3 are all TATA-less Acknowledgements promoters. Promoters P1 and P2 both contain CATAA sequences located a few bases upstream from their respective This work was supported by a VA Merit Award grant to GEA. transcription initiation sites. We have previously shown that the CATAA sequence in the human homologue of promoter P1 appears to be critical for activity of that promoter, 18 sugReferences gesting that the same may be true for murine promoter P1 and perhaps also for murine promoter P2. The murine P1 segment
